Vivozon Pharmaceutical Statistics

Total Valuation

KOSDAQ:082800 has a market cap or net worth of KRW 290.84 billion. The enterprise value is 321.12 billion.

Market Cap	290.84B
Enterprise Value	321.12B

Important Dates

The last earnings date was Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:082800 has 49.38 million shares outstanding. The number of shares has increased by 1.50% in one year.

Current Share Class	49.38M
Shares Outstanding	49.38M
Shares Change (YoY)	+1.50%
Shares Change (QoQ)	+1.58%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	n/a
Float	17.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.37
PB Ratio	2.85
P/TBV Ratio	2.97
P/FCF Ratio	n/a
P/OCF Ratio	62.64
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-25.15
EV / Sales	3.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-303.96

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.36.

Current Ratio	0.57
Quick Ratio	0.09
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	-34.67
Interest Coverage	-2.18

Financial Efficiency

Return on equity (ROE) is -13.15% and return on invested capital (ROIC) is -2.23%.

Return on Equity (ROE)	-13.15%
Return on Assets (ROA)	-1.79%
Return on Invested Capital (ROIC)	-2.23%
Return on Capital Employed (ROCE)	-4.66%
Revenue Per Employee	263.21M
Profits Per Employee	-38.93M
Employee Count	328
Asset Turnover	0.49
Inventory Turnover	2.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +98.32% in the last 52 weeks. The beta is -0.77, so KOSDAQ:082800's price volatility has been lower than the market average.

Beta (5Y)	-0.77
52-Week Price Change	+98.32%
50-Day Moving Average	6,471.00
200-Day Moving Average	6,210.40
Relative Strength Index (RSI)	30.69
Average Volume (20 Days)	108,529

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:082800 had revenue of KRW 86.33 billion and -12.77 billion in losses. Loss per share was -264.11.

Revenue	86.33B
Gross Profit	45.10B
Operating Income	-5.01B
Pretax Income	-13.36B
Net Income	-12.77B
EBITDA	-1.23B
EBIT	-5.01B
Loss Per Share	-264.11

Full Income Statement

Balance Sheet

The company has 6.35 billion in cash and 36.63 billion in debt, giving a net cash position of -30.28 billion or -613.18 per share.

Cash & Cash Equivalents	6.35B
Total Debt	36.63B
Net Cash	-30.28B
Net Cash Per Share	-613.18
Equity (Book Value)	101.95B
Book Value Per Share	2,064.76
Working Capital	-31.19B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.64 billion and capital expenditures -5.70 billion, giving a free cash flow of -1.06 billion.

Operating Cash Flow	4.64B
Capital Expenditures	-5.70B
Free Cash Flow	-1.06B
FCF Per Share	-21.40

Full Cash Flow Statement

Margins

Gross margin is 52.24%, with operating and profit margins of -5.81% and -14.79%.

Gross Margin	52.24%
Operating Margin	-5.81%
Pretax Margin	-15.48%
Profit Margin	-14.79%
EBITDA Margin	-1.43%
EBIT Margin	-5.81%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:082800 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.50%
Shareholder Yield	n/a
Earnings Yield	-4.39%
FCF Yield	-0.36%

Stock Splits

The last stock split was on October 20, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Oct 20, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

KOSDAQ:082800 has an Altman Z-Score of -0.05. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.05
Piotroski F-Score	n/a